Measurement of serum prostate specific antigen using IMx prostate specific antigen assay.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Urology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5347(17)34879-6PMID 7504749
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Defining and updating the american cancer society guidelines for the cancer‐related checkup: Prostate and endometrial cancers

  1993cited by this paper
• Abbott IMx evaluated for assay of prostate-specific antigen in serum.

  1992cited by this paper
• Prostate-specific antigen comes of age in diagnosis and management of prostate cancer.

  1992cited by this paper
• Ultrasensitive radioimmunoassay of prostate-specific antigen.

  1992cited by this paper
• Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen.

  1992cited by this paper
• Prostate specific antigen predominantly forms a complex with alpha1‐antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum

  1992cited by this paper
• American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays. The Committee on Nomenclature of the American Thyroid Association.

  1991cited by this paper
• A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.

  1991cited by this paper
• Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

  1991cited by this paper
• Comparison of a polyclonal and monoclonal immunoassay for PSA: need for an international antigen standard.

  1990cited by this paper
• Clinical review 12: The use and misuse of the sensitive thyrotropin assays.

  1990cited by this paper
• Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors.

  1990cited by this paper
• Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation.

  1989cited by this paper
• The Abbott IMx automated benchtop immunochemistry analyzer system.

  1988cited by this paper
• Assessment of sensitive thyrotropin assays for an expanded role in thyroid function testing: proposed criteria for analytic performance and clinical utility.

  1987cited by this paper

• Journal of Pharmaceutical and Biological Sciences

  2015cites this paper
• Changes in Serum PSA During Normal Menstrual Cycle

  2012cites this paper
• Pretreatment Tumor Volume Estimation Based on Total Serum PSA in Patients with Localized Prostate Cancer

  2008cites this paper
• Prediction of radial distance of extraprostatic extension from pretherapy factors.

  2007cites this paper
• Determination of biochemical relapse after radical prostatectomy by biological detection limit (BDL) after cystoprostatectomy using two PSA assays.

  2005cites this paper
• Caveolin‐1 expression is a predictor of recurrence‐free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients

  2003cites this paper
• Neurogenic Vesical Dysfunction

  2003cites this paper
• A standard definition of disease freedom is needed for prostate cancer: undetectable prostate specific antigen compared with the American Society of Therapeutic Radiology and Oncology consensus definition.

  2002cites this paper
• Evaluation of total PSA assay on vitros ECi and correlation with Kryptor-PSA assay.

  2001cites this paper
• Role of Preoperative Positive Apical Biopsies in the Prediction of Specimen–Confined Prostate Cancer after Radical Retropubic Prostatectomy: A Multi–Institutional Study

  2000cites this paper
• Is there a role for digital rectal examination in the followup of patients after radical prostatectomy?

  1999cites this paper
• Supersensitive PSA-analysis after radical prostatectomy: a powerful tool to reduce the time gap between surgery and evidence of biochemical failure.

  1999cites this paper
• Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.

  1999cites this paper
• Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.

  1999cites this paper
• [Implication of two additional lateral peripheral zone biopsy in the detection of prostate cancer].

  1999cites this paper
• [Indication of repeat prostatic biopsy following previous negative findings].

  1999cites this paper
• [Histological characteristics and clinical significance of Japanese prostate cancer with low levels of prostate specific antigen of 4.0 ng/ml or lower].

  1999cites this paper
• Improved predictability of extracapsular extension and seminal vesicle involvement based on clinical and biopsy findings in prostate cancer in Japanese men.

  1998cites this paper
• PSA-Screening beim Prostatakarzinom

  1998cites this paper
• Prostate-Specific Antigen and New Related Markers for Prostate Cancer

  1998cites this paper
• Zonal biopsy in the detection of prostate cancer in Japanese men.

  1998cites this paper
• Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: lack of significance for microvessel density analysis.

  1998cites this paper
• Results of transrectal ultrasound-guided biopsies and clinical significance of Japanese prostate cancer.

  1998influential citation
• Electrochemical enzyme immunoassay for serum prostate-specific antigen at low concentrations.

  1997cites this paper
• Nonprostatic sources of prostate-specific antigen.

  1997cites this paper
• Diagnosis, management and screening of early localised prostate cancer.

  1997cites this paper
• An enhanced prognostic system for clinically localized carcinoma of the prostate

  1997cites this paper
• Prospective evaluation of prostate specific antigen density and systematic biopsy for detecting prostate cancer in Japanese patients with normal rectal examinations and intermediate prostate specific antigen levels.

  1997cites this paper
• Cardiac troponin T in serum as marker for myocardial injury in newborns.

  1997cites this paper
• Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy.

  1997cites this paper
• Re: Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation.

  1997cites this paper
• A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma

  1997cites this paper
• Significance of preoperative parameters for predicting tumor volume in nonpalpable prostate cancer.

  1996cites this paper
• Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens.

  1996cites this paper
• Preoperative serum prostate-specific antigen, clinical stage and Gleason sum as basis for predicting final pathological stage in Japanese patients with prostate cancer.

  1996cites this paper
• Lower limits of detection, biological detection limits, functional sensitivity, or residual cancer detection limit? Sensitivity reports on prostate-specific antigen assays mislead clinicians.

  1996influential citation
• Predictive properties of serum-prostate-specific antigen testing in a community-based setting.

  1996cites this paper
• Ultrasensitive prostate-specific antigen assays and their clinical application.

  1996cites this paper
• Ejaculation increases the serum prostate-specific antigen concentration.

  1996cites this paper
• The definition and preoperative prediction of clinically insignificant prostate cancer.

  1996cites this paper
• Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens.

  1996cites this paper
• Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation.

  1996cites this paper
• Role of free PSA in discordance across commercial PSA assays.

  1996cites this paper
• Strip test for the quick detection of increased concentrations of prostate-specific antigen in blood.

  1996cites this paper
• Supersensitive detection of prostate-specific antigen in lyophilisation-concentrated serum.

  1996cites this paper
• The Role of Prostate-Specific Antigen in the Management of Prostate Cancer

  1996cites this paper
• 2064 Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy

  1996cites this paper
• 14 The Role of Prostate-Specific Antigen in the Management of Prostate Cancer

  1996cites this paper
• A guide to the interpretation of serum prostate specific antigen levels.

  1995cites this paper
• Analytical quality specifications for reference methods and operating specifications for networks of reference laboratories. discussion paper from the members of the external quality assessment (EQA) Working Group B1) on target values in EQAS.

  1995cites this paper
• Variation in measurement of prostate-specific antigen: importance of method and lot variability.

  1995cites this paper
• Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men.

  1995cites this paper
• Multicentre evaluation of a non-wipe system for the rapid determination of total cholesterol in capillary blood, Accutrend Cholesterol on Accutrend GC.

  1995cites this paper
• Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part II: Early detection strategies.

  1995cites this paper
• Stability of serum prostate-specific antigen determination across laboratory, assay, and storage time.

  1995cites this paper
• Third-Generation Psa: Ultrasensitive or Ultraprecise Assay?

  1995cites this paper
• Early detection of prostate cancer. Results of a prostate specific antigen‐based detection program in Japan

  1995cites this paper
• Prostate-Specific Antigen and Detecting Early Prostate Cancer: The Importance of Race and Patient Age

  1995cites this paper
• Cancer (prostate-specific antigen).

  1995cites this paper
• Multicentre evaluation of a new fully automated enzyme immunoassay for total prostate-specific antigen.

  1995cites this paper
• Evaluation of the COBAS CORE Immunoassay for measuring prostate-specific antigen (PSA)--multi-centre study results. The PSA Study Group.

  1995cites this paper
• Comparison of kits for the determination of creatine kinase activity in serum.

  1995cites this paper
• [Usefulness of hyper sensitive PSA assay kits for determination on low range of prostate specific antigen in prostate cancer].

  1995cites this paper
• Assay variability in serum prostate‐specific antigen determination

  1995cites this paper
• Costs and Effectiveness of Prostate Cancer Screening in Elderly Men (Part 10 of 16)

  1995cites this paper
• The analytical and clinical performance of the new Boehringer Mannheim Enzymun-Test PSA assay for prostate-specific antigen.

  1995cites this paper
• Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density.

  1994cites this paper
• Patient evaluation if prostate-specific antigen becomes elevated following radical prostatectomy or radiation therapy.

  1994cites this paper
• Prostate-specific antigen: concepts for staging prostate cancer and monitoring response to therapy.

  1994cites this paper
• [Tumor marker in prostate cancer].

  1994cites this paper
• Immunohistochemical localization of prostate-specific markers within the accessory male sex glands of Cowper, Littre, and Morgagni.

  1994cites this paper
• Development of a highly sensitive immunochemiluminometric assay for prostate-specific antigen.

  1994cites this paper